Medicine
Exemestane 25 mg tablet
Exemestane 25 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Exemestane
- Brand
- Sold under the generic name
- Strength
- 25 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets and 8 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaCiplaIndiaBreckenridge PharmaceuticalBryant Ranch PrepackFlorida Pharmaceutical ProductsMylan PharmaceuticalsNorthStar RxOPKO PharmaceuticalsUpsher-Smith Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BG06 Exemestane
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 April 2011
- Identifiers
- RxCUI 310261DailyMed set ID e24b08eb-4693-41c7-81cb-b536947f7070, 69abd0ff-b200-4d1a-b14a-80e980a8e781, 392b5b4f-3fb4-4ba7-a15a-6022298db719 +8NDC 59651-516, 59762-2858, 70301-2017 +8Application ANDA216454, NDA020753, ANDA200898 +5
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet in 1 bottle | 68382-383-06 | Zydus LifesciencesIndia | 8 October 2018 |
| 30 tablet in 1 bottle | 70771-1374-3 | Zydus LifesciencesIndia | 8 October 2018 |
| 30 tablet, film coated in 1 bottle | 59651-516-30 | Aurobindo PharmaIndia | 20 May 2022 |
| 30 tablet in 1 bottle | 69097-316-02 | CiplaIndia | 27 April 2018 |
| 90 tablet, film coated in 1 bottle | 51991-005-90 | Breckenridge Pharmaceutical | 15 November 2020 |
| 30 tablet, film coated in 1 bottle | 71921-190-33 | Florida Pharmaceutical Products | 15 January 2021 |
| 30 tablet, sugar coated in 1 bottle | 59762-2858-1 | Mylan Pharmaceuticals | 1 April 2011 |
| 30 tablet, coated in 1 bottle | 70301-2017-1 | OPKO Pharmaceuticals | 31 October 2026 |
| 30 tablet in 1 bottle | 0832-0595-30 | Upsher-Smith Laboratories | 27 July 2017 |
| 30 tablet, film coated in 1 bottle | 63629-2056-1 | Bryant Ranch Prepack | 19 December 2019 |
| 30 tablet, film coated in 1 bottle | 72603-329-01 | NorthStar Rx | 1 January 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 21 October 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Exemestane 25 mg tablet.
Clinical summary
Exemestane is an aromatase inhibitor indicated for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Exemestane for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ExemestaneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- EXEMESTANE prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Exemestane 25 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.